GlassScriptPhysician profile
Jason M Grossman
NPI 1720079239
$6,602.00
in general payments reported to CMS, 2019-2025
23 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $874 · 2020: $378 · 2021: $1,158 · 2022: $1,348 · 2023: $1,079 · 2024: $1,104 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,748 · Travel and Lodging: $96.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,747.93 |
| Travel and Lodging | $96.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,241.55 | 2019-2025 | Variax, Inbone, Actishield |
| Zimmer Biomet Holdings, INC. | $673.80 | 2020-2022 | |
| Bioventus LLC | $441.29 | 2019-2022 | |
| Wright Medical Technology, INC. | $223.59 | 2019 | |
| Paratek Pharmaceuticals, INC. | $197.55 | 2022-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $106.76 | 2023-2025 | |
| Cardiovascular Systems INC. | $97.81 | 2020-2021 | |
| Integra Lifesciences Corporation | $75.24 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $70.33 | 2019-2024 | Stravix Pl, Grafix Pl |
| Abbott Laboratories | $65.58 | 2021 | |
| Cashflow Solutions, LLC | $60.84 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Medtronic, INC. | $48.85 | 2024 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $42.80 | 2019 | |
| Horizon Therapeutics Plc | $41.82 | 2020-2023 | Krystexxa |
| Paragon 28, INC. | $41.09 | 2021-2024 | Precision Mis Bunion |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $38.74 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.88 | 2023-2024 | Jublia |
| Lifenet Health | $25.52 | 2025 | Graftlink Ts |
| Kerecis Limited | $21.18 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Assertio Therapeutics, INC. | $15.42 | 2020 | |
| Zimvie INC. | $15.20 | 2023 | |
| Medtronic Vascular, INC. | $13.51 | 2019 | |
| Sebela Pharmaceuticals INC. | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.